We are live on
!
Find out more
AC
Amici Capital Portfolio holdings
AUM
$257M
1-Year Est. Return
4.88%
This Fund
S&P 500
This Quarter
Est. Return
+1.98%
1 Year Est. Return
+4.88%
3 Year Est. Return
+28.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$257M
AUM Growth
-$126M
(-33%)
Cap. Flow
-$80.2M
Cap. Flow
% of AUM
-31.15%
Top 10 Holdings %
Top 10 Hldgs %
54.36%
Holding
106
New
17
Increased
10
Reduced
24
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FBNK
First Connecticut Bancorp, Inc
FBNK
|
+$5.04M |
| 2 |
Hecla Mining
HL
|
+$2.74M |
| 3 |
Assured Guaranty
AGO
|
+$2.52M |
| 4 |
RRD
RR Donnelley & Sons Co.
RRD
|
+$898K |
| 5 |
LKSD
LSC Communications, Inc.
LKSD
|
+$445K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$7.33M |
| 2 |
Meta Platforms (Facebook)
META
|
+$5.8M |
| 3 |
VISN
Vistance Networks Inc
VISN
|
+$5.79M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$5.45M |
| 5 |
Integer Holdings
ITGR
|
+$5.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.64% |
| 2 | Financials | 12.96% |
| 3 | Communication Services | 9.84% |
| 4 | Materials | 7.48% |
| 5 | Industrials | 1.39% |
Similar funds
GFG
CAM
SCMC
AS
BREA
BGE
JIAI
SIG
Amici Capital's Q4 2016 Portfolio in Review
As of Q4 2016, Amici Capital held 106 positions worth $257M, down 33% from $383M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Amici Capital withdrew a net $80.2M in Q4 2016, closing 48 positions and reducing 24 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $5.45M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 27% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Amici Capital opened a new position in First Connecticut Bancorp, Inc worth $32K.
- Amici Capital's largest Q4 2016 buy was First Connecticut Bancorp, Inc: 250,000 shares worth $32K.
- Amici Capital added most to Hecla Mining in Q4 2016, an estimated $2.74M increase.
- Amici Capital's biggest Q4 2016 reduction was BioMarin Pharmaceuticals, cutting an estimated $7.33M.
- Amici Capital fully exited Teva Pharmaceuticals in Q4 2016, selling an estimated $5.45M.
- Amici Capital's ten largest holdings make up 54% of its $257M portfolio in Q4 2016.
- Amici Capital opened 17 new positions and closed 48 in Q4 2016.
- Amici Capital's portfolio value fell 33% quarter-over-quarter to $257M.
Based on Amici Capital's 13F filing for Q4 2016, filed 14 Feb 2017.